Lifeboat Foundation

A disclaimer on the new article that I wrote: while I do think the Beta-amyloid plaque plays a key role in the development of Alzheimer’s disease I do not think it’s the only thing. I’ll be writing more on Alzheimer’s disease as I study more.

The abnormal accumulation β-amyloid peptide is the leading candidate for the cause of Alzheimer’s disease is currently ranked the 6 th leading cause of death in the United States while some statistics claim it may rank as high as the third leading cause of death.

What is Alzheimer’s disease?

Continue reading “Deletion of BACE 1 Enzyme Reverses The Symptoms of Alzheimer’s” »

Physicists Pinpoint The Origin Of A Powerful Neutrino For The First Time Ghostly particles called neutrinos can travel nearly unimpeded across the universe. For the first time, physicists have been able to pinpoint the origin of a powerful neutrino.

DPRK’s letter to Trump.

Based on NASA’s “schedule risk analysis” from April, the agency estimates that Boeing will reach this milestone sometime between May 1, 2019, and August 30, 2020. For SpaceX, the estimated range is August 1, 2019, and November 30, 2020.

Both of the companies are well behind schedule, forcing the agency to scramble.

The abnormal accumulation β-amyloid peptide is the leading candidate for the cause of Alzheimer’s disease. Alzheimer’s disease is currently ranked the 6th leading cause of death in the United States while some statistics claim it may rank as high as the third leading cause of death.

What is Alzheimer’s disease?

Alzheimer’s is a slowly progressive disease that causes the loss of memories and cognitive function. It is the most common form of dementia and accounts for 60 to 80% of cases.

Continue reading “Deletion of BACE 1 Enzyme Reverses The Symptoms of Alzheimer's” »

Water-bearing minerals reveal that Earth’s mantle could hold more water than all its oceans. Researchers now ask: Where did it all come from?

It’s in a bad taste to say that other global issues are more urgent than ageing, when pretty much all global issues—ageing included—affect the life, and the quality of life, of many people.

Suppose you’re in your mid-seventies, and you find out that your aortic valve doesn’t work very well. Undergoing a replacement operation—nowadays, a relatively simple and safe procedure—is not only going to help you with your unpleasant episodes of fatigue, chest pain, and dizziness, it may well save your life, minimizing your risk of sudden cardiac arrest.

Your doctor suggests that you undergo the procedure and sends you to a surgeon for the operation; however, when you get there, the surgeon starts yelling at you that, rather than using resources to replace your valve and extend your life, we should fund initiatives to save children in poor countries, build health clinics, train midwives, and fight for equal opportunity and for women’s rights. He then goes on rambling that, until these issues are addressed, he doesn’t want to hear about extending your natural lifespan—after all, since you’re in your mid-seventies, you’re well above the world’s average lifespan; he shoos you and your family out and slams the door on you.

Continue reading “Minoring in the majors” »

Pills hailed as the first real “anti-aging” drugs inched a little closer to the market after a study found they cut the number of respiratory infections in the elderly by half.

The drugs: The pills act on an aging-related pathway called TORC1. Inhibiting this pathway “has extended life span in every species studies to date” (like mice and worms), according to Joan Mannick, who lead the study for drug giant Novartis.

Will humans live longer, too? Maybe. But that will take time to figure out. For now, what’s known is that giving people 65 and older these drugs seems to boost their immune function. Elderly people taking the drugs got about 40 percent fewer colds or bronchial infections. About 264 people got the drugs over six weeks and then were tracked for a year.

Continue reading “These anti-aging pills look like they’re actually working” »

About 40 percent of all the energy consumed by buildings worldwide is used for space heating and cooling. With the warming climate as well as growing populations and rising standards of living—especially in hot, humid regions of the developing world—the level of cooling and dehumidification needed to ensure comfort and protect human health is predicted to rise precipitously, pushing up global energy demand.

Much discussion is now focusing on replacing the greenhouse gases frequently used as refrigerants in today’s air conditioners. But another pressing concern is that most existing systems are extremely energy-inefficient.

“The main reason they’re inefficient is that they have two tasks to perform,” says Leslie Norford, the George Macomber (1948) Professor in Construction Management in the Department of Architecture. “They need to lower temperature and remove moisture, and doing both those things together takes a lot of extra energy.”